Andrew Liss

BACKGROUND: Pancreatic ductal adenocarcinoma (PDA) is highly malignant and often leads to a loss of skeletal muscle mass and sarcopenia, which is associated with poor outcomes…

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer deaths with a survival rate of less than 11%. A prominent feature of PDAC is its highly desmoplastic reaction, characterized by an abundance of extracellular matrix (ECM) in primary and metastatic tumors…